期刊文献+

甲状旁腺激素与尿毒症继发甲状旁腺功能亢进术后病理的相关性研究 被引量:10

Correlation study between parathyroid hormone level and pathological findings of parathyroid surgical samples in uremic patients with hyperparathyroidism
暂未订购
导出
摘要 目的通过对尿毒症继发难治性甲状旁腺功能亢进行甲状旁腺切除术后的甲状旁腺组织病理观察,分析不同程度甲状旁腺激素水平患者的病理结果是否存在差异。方法在2009年9月~2012年1月期间在中日友好医院进行甲状旁腺切除手术(PTX)的46例尿毒症透析患者的甲状旁腺组织进行病理形态分析。根据甲状旁腺激素(i PTH)水平分组,A组i PTH<1000pg/ml,B组i PTH1000pg/ml^2000pg/ml,C组i PTH>2000pg/ml;同时依据透析龄10年以上和10年以下分2组。比较3组间实验室指标的差异及甲状旁腺组织的病理形态差异;比较不同透析龄分组,甲状旁腺组织的病理形态差异。结果 3组间Ca、P和透析龄之间均无显著性差异(P>0.05);3组i PTH组间均有显著性差异(P=0.000);3组间比较碱性磷酸酶(ALP)有显著性差异[(216.00±196.81)U/L,(463.45±363.35)U/L,(619.55±377.50)U/L,P=0.014],ALP的组间均值随i PTH的升高而大幅度升高,与i PTH的升高成正比。病理形态比较3组中均出现陈旧性出血、嗜酸性细胞、水样透明细胞、腺样结构及病变区钙化和血管壁钙化等病变。以透析龄10年为界进行比较,甲状旁腺出现钙化、血管壁钙化的比例分别为透析10年以下组23.1%和透析10年以上组78.9%,2组间具有显著性差异(P=0.000)。结论 i PTH的水平与ALP的升高呈正相关;钙化和血管壁钙化与透析时间长短相关;而i PTH水平的高低与继发甲状旁腺功能亢进病理变化无相关性。 Objectives To analyze the relationship between parathyroid hormone (PTH) level and pathological changes in parathyroid of hyperparathyroidism through pathological examination of the surgical samples after parathyroidectomy (PTX). Methods A total of 46 dialysis patients with refractory hyperparathy- roidism and treated with PTX in China-Japan Friendship Hospital during the period from Sep. 2009 to Jan. 2012 were enrolled in this study. They were divided into 3 groups based on iPTH level: group A (iPTH 〈 1,000 pg/ml), group B (iPTH 1,000-2,000 pg/ml), and group C (iPTH 〉2,000 pg/ml). They were also divided into dialysis age 〉10 years group and dialysis age 〈10 years group. Laboratory examinations and pathological findings in the parathyroid surgical samples were compared among the 3 groups. Pathological findings in the parathyroid surgical samples were also compared in patients with different dialysis age. Results Ca, P and dialysis age had no differences (P〉0.05), but iPTH and alkaline phosphatase (ALP) levels were significantly different among the 3 groups (P=0.000 and 0.014, respectively). Group C had the highest mean ALP value, followed by group B and group A. Old hemorrhagic loci, eosinophilic cells, transparent cells, adenoid structure, tissue calcification, and vascular wall calcification were seen in the 3 groups. The rate of calcification in parathyroid gland and vascular wall was 23.1% in patients with dialysis age of 〈10 years, and was 78.9% in those with dialysis age of 〉10 years (P=-0.000). Conclusion iPTH levels were positively correlated with the level of ALP. Calcification in parathyroid gland and vascular wall was positively correlated with dialysis age. However, iPTH level was unrelated to the pathological changes of hyperparathyroidism in parathyroid.
出处 《中国血液净化》 2015年第12期732-735,共4页 Chinese Journal of Blood Purification
关键词 继发性甲状旁腺功能亢进 甲状旁腺激素 碱性磷酸酶 透析龄 Secondary hyperparathyroidism Parathyroid hormone Alkaline phosphatase Dialysis age
  • 相关文献

参考文献10

  • 1Malbcrti F, Marcelli D, Conte F,et al. Parathyroidecto-my in patients on renal replacement therapy: an epide-miologic study[J]. J Am Soc Nephrol, 2001,12 (6):1242-1248.
  • 2段定红,黄敏丽.骨代谢生化指标与骨质疏松症[J].上海医学,1999,22(12):765-767. 被引量:12
  • 3Epstein S. Serum and urinary marker8 of bone remodel-ing: assess-ment of bone turnover[J]. Endocrine Rev,1988,9(4):437-449.
  • 4蒋中良,张艳,王莉,付计峰.尿毒症维持性血液透析患者甲状旁腺素与血清碱性磷酸酶的相关性分析[J].中国基层医药,2011,18(18):2542-2543. 被引量:4
  • 5李铎,宋韩明,李文歌,姚力,张国锐,陈少轩,张凌.难治性继发性甲状旁腺功能亢进的相关因素分析[J].肾脏病与透析肾移植杂志,2012,21(2):115-119. 被引量:38
  • 6Kovesdy CP,Ureche V, Lu 几,et al. Outcome predictabil-iy of serumalk aline phosphatase in men with pre-dialy-sis CKD[j]. Nephrol Dial Transplant, 2010, 25 (9):3003-3011.
  • 7Kidney Disease: Improving Global Outcomes (KD1G0) CKD-MBD Work Group. KDIG0 clinical practice guideline forthe diagnosis, evaluation, prevention, and treatmentof Chronic Kidney Disease- Mineral and Bone Disorder(CKD-MBD).[J]. Kidney Int Suppl, 2009, (113):S1-130.
  • 8张凌,闫彩芸,姚力.难治性继发性甲状旁腺功能亢进症的外科治疗[J].中国血液净化,2012,11(7):349-351. 被引量:17
  • 9Shih ML, Duh QY, Hsieh CB, et al . Total parathyroidec-tomy without autotransplantation for secondary hyper-parathyroidism. [J] . World J Surg, 2009,33(2) :248-254.
  • 10Puccini M, Carpi A, Cupisti A, et al. Total parathy-roidectomy without autotransplantation for the treat-ment of secondary hyperparathyroidism associated withchronic kidney disease: clinical and laboratory long-term follow-up. [J]. Biomed Pharmacothor, 2010, 64(5):359-362.

二级参考文献46

  • 1<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 2Slatopolsky E, Brown A, Dusso A. Role of phosphorus in the patho- genesis of secondary hyperparathyroidism. Am J Kidney Dis,2001, 37( 1 ) :54-57.
  • 3Epstein S. Serum and urinary markers of bone remodeling:assess- ment of bone turnover. Endocrine Rev, 1988,9 (4) :437-449.
  • 4Moorthi RN, Moe SM. CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis,2011,58 (6) : 1022 - 1036.
  • 5Basile C,Lomonte C,Vernaglione L,et al. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant,2006,21 (4) : 968 - 974.
  • 6Almaden Y, Felsenfeld A J, Rodriguez M, et al. Proliferation in hyperplastic human and normal rat parathyroid glands:Role of phosphate, calcitriol and gender. Kidney Int,2003,64(6) :2311 -2317.
  • 7Sela-Brown A, Silver J, Brewer G, et al. Identification of AUF1 as a parathyroid hormone mRNA 3-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J Biol Chem,2000, 275 (10) :7424 - 7429.
  • 8Schwarz S, Trivedi BK, Kalantar-Zadeh K, et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephro1,2006,1 (4) :825 - 831.
  • 9Noofi N, Kalantar-Zadeh K, Kovesdy CP, et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol, 2010, 5 (4) :683 -692.
  • 10Suwan N. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital. J Med Assoc Thai ,2011,94 ( Suppl 4) : SI01 - 105.

共引文献67

同被引文献109

  • 1陈伟,崔天蕾,谢林伸,李昕怡,吴敬.不同血液净化方式对维持性血液透析患者微炎症状态和营养状态的影响[J].中国老年学杂志,2015,35(2):379-380. 被引量:45
  • 2陈欣,季大玺.高通量血液透析[J].肾脏病与透析肾移植杂志,2005,14(1):78-81. 被引量:67
  • 3季大玺,龚德华.高通量血液透析的临床应用体会[J].肾脏病与透析肾移植杂志,2005,14(3):249-250. 被引量:13
  • 4Slinin Y, Foley RN. Collins AJ. Clinical epidemiology of parathyroidec- tomy in hemodialysis patients : the USRDS waves 1,3, and 4 study [ J ]. Hemodial Int,2007,11 ( 1 ) :62-71.
  • 5Yu N, Leese GP, Donnan PT. What predicts adverse outcomes in un- treated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS) [ J ]. Clin Endocrinol (Oxf), 2013,79( 1 ) :27-34.
  • 6Ballegooijen AVJ, Reinders I, Visser M, et al. Serum parathyroid hor- mone in relation to all-canse and cardiovascular mortality:the Hoom study[J]. J Clin Endocrinol Metab,2013,98(4) :e638-645.
  • 7Kritehevsky SB, Tooze JA, Neiberg RH, et al. 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults : the health ABC study[J]. J Clin Endocrinol Metab,2012,97( 11 ) :4156- 4165.
  • 8Ballegooijen AVJ, Robinson-Cohen C, Katz R, et al. Vitamin D metab- olites and bone mineral density : The multi-ethnic study of atheroselero- sis[ J]. Bone,2015,78 : 186-193.
  • 9Pilz S, Gaksch M, Kienreich K, et al. Effects of vitamin D on blood pressure and cardiovascular risk factors : a randomized controlled trial [ J ]. Hypertension,2015,65 (6) : 1195-1201.
  • 10Torun D, Yildiz I, Micozkadioglu H, et al. The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ven- tricular mass index and parathyroid gland volume in hemodialysis pa- tients with severe secondary hyperparathyroidism[ J]. Saudi J Kidney Dis Transp1,2016,27 ( 1 ) : 15-22.

引证文献10

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部